Science Explorer Interactive view Map
Company · San Diego · United States

ViaCyte (United States)

Research works
29
▼ 44% vs 2013–17
Citations
2.3k
80.2 per fractional work
Top-10% rate
9.2%
record average 16.5%
Open access
51%
world 28%

Not ranked overall: ViaCyte (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 1.15× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 4.80× its world share, 1 worksBiochemistry, Geneti…Immunology and Microbiology: 1.81× its world share, 0 worksImmunology and Micro…Computer Science: 0.31× its world share, 0 worksComputer ScienceEngineering: 0.04× its world share, 0 worksEngineeringMedicine: 3.33× its world share, 3 worksMedicineworld share
more than its size predictsabout as predictedless

Rings at 0.5×, and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 4.8×. Every wedge is a field page.

Which keywords describe research at ViaCyte (United States)?

By fractional works in all years, weighted toward what it does more of than the world: Oxidative Stress, Type 1 Diabetes, Pancreatic Islets, ß-Cell Dysfunction, Immunotherapy, Transcriptional Regulation, Induced Pluripotent Stem Cells and Pluripotent Stem Cells.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 27 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 27 words, with their numbers
  1. Oxidative Stress4▲ 7.2×2 topics
  2. Type 1 Diabetes4▲ 133×2 topics
  3. Pancreatic Islets4▲ 183×1 topic
  4. ß-Cell Dysfunction4▲ 183×1 topic
  5. Immunotherapy3▲ 16×9 topics
  6. Transcriptional Regulation2▲ 33×3 topics
  7. Induced Pluripotent Stem Cells2▲ 229×1 topic
  8. Pluripotent Stem Cells2▲ 116×1 topic
  9. Targeted Therapy2▲ 37×4 topics
  10. Diabetes2▲ 14×2 topics
  11. Hypoglycemia2▲ 155×1 topic
  12. Insulin Therapy2▲ 64×1 topic
  13. Cell-Free DNA2▲ 62×2 topics
  14. Epidemiology2▲ 1.41×3 topics
  15. Genetics2▲ 7.2×3 topics
  16. Genomic Instability2▲ 44×2 topics
  17. Autoimmunity2▲ 26×1 topic
  18. Cancer Genomics2▲ 94×1 topic
  19. HLA Genes2▲ 112×1 topic
  20. Mutational Signatures2▲ 94×1 topic
  21. Chemotherapy1▲ 6.2×8 topics
  22. Clinical Trials1▲ 7.0×4 topics
  23. Cancer1▲ 2.8×6 topics
  24. Genetic Mutations1▲ 7.8×4 topics
  25. Genomic Profiling1▲ 39×2 topics
  26. Online Social Networks1▲ 148×1 topic
  27. Privacy Concerns1▲ 78×1 topic

Which research topics does ViaCyte (United States) publish most on?

By volume in 2022–2025: Medical Imaging Techniques and Applications, Radiomics and Machine Learning in Medical Imaging, Cancer Genomics and Diagnostics and Plant Virus Research Studies.

  1. 1 Medical Imaging Techniques and Applications Radiology, Nuclear Medicine and Imaging 0 works
  2. 2 Radiomics and Machine Learning in Medical Imaging Radiology, Nuclear Medicine and Imaging 0 works
  3. 3 Cancer Genomics and Diagnostics Cancer Research 0 works
  4. 4 Plant Virus Research Studies Plant Science 0 works
  5. 5 Prostate Cancer Treatment and Research Pulmonary and Respiratory Medicine 0 works
  6. 6 Polyomavirus and related diseases Oncology 0 works
  7. 7 Cancer Cells and Metastasis Oncology 0 works
  8. 8 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 0 works
  9. 9 Bioinformatics and Genomic Networks Molecular Biology 0 works
  10. 10 Gene expression and cancer classification Molecular Biology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available50.7%not open49.3%

World: 28% of research is openly available.

with international co-authors32.0%domestic only68.0%

World: 19% is written across borders.

How has ViaCyte (United States)'s research output changed?

Output in 2018–2022 was 44% lower than in 2013–2017.

20002005201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in San Diego

All research institutions in San Diego

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.